Crisis Communication

Crisis in the News: Psoriasis drug could be linked to four deaths

Posted on: February 22, 2009

WebMD article

LA Times Blog

Genentech could have a possible crisis on its hands due to the recent public health advisory for its drug Raptiva, which treats psoriasis. The company appears to be handling it well.

WebMD says, “According to the FDA, there have been three confirmed and one possible case of progressive multifocal leukoencephalopathy (PML) in people taking Raptiva; three of those people died.”

The FDA issued a warning about Raptiva last October.

There is not yet much information about this. In the articles I have come across have responses from spokespeople, who assure readers that Genentech is working with the FDA.

I think this could evolve into a problem if Raptiva is found to be the cause of PML, and if more people die from the drug.

Advertisements

1 Response to "Crisis in the News: Psoriasis drug could be linked to four deaths"

This is a problem, thanks for sharing.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: